COMBINED CONTROLLED-RELEASE PHARMACEUTICAL AGENT CONTAINING DIHYDROPYRIDINE CALCIUM CANAL BLOCKERS AND HMG-CoA-REDUCTASE INHIBITORS

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to medicine and may be used for treating patients with hypertension and lipid storage disease. There is applied a combined drug containing dihydropyridine, calcium canal blockers, and statin, a hypolipidemic agent. The drug is prepared in such a manner that release rate of said ingredients can be controlled with respect to each other.;EFFECT: method allows higher clinical effectiveness and compliance, prevented antagonist and side effects of the combined therapy.;27 cl, 12 tbl, 10 dwg, 7 ex